Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines

Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia

(2011) Yoshikane Kikushige et al.   CANCER CELL

The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia

(2011) P. Ouillette et al.   CLINICAL CANCER RESEARCH

13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

(2011) Michele Dal Bo et al.   GENES CHROMOSOMES & CANCER

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

(2011) R. Gunnarsson et al.   HAEMATOLOGICA

Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation

(2011) Giulia Fabbri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

(2011) Xose S. Puente et al.   NATURE

13q14 deletions in CLL involve cooperating tumor suppressors

(2010) A. Palamarchuk et al.   BLOOD

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia

(2010) H Parker et al.   LEUKEMIA

New insights into the pathogenesis of chronic lymphocytic leukemia

(2010) Ulf Klein et al.   SEMINARS IN CANCER BIOLOGY

Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region

(2010) Aybike Birerdinc et al.   TUMOR BIOLOGY

MicroRNAs in Cancer

(2009) Ramiro Garzon et al.   Annual Review of Medicine

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

(2009) Mikael Lerner et al.   EXPERIMENTAL CELL RESEARCH

Identification of the Human Mature B Cell miRNome

(2009) Katia Basso et al.   IMMUNITY

B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia

(2009) Ola Landgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

(2008) A. Lanemo Myhrinder et al.   BLOOD

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA

(2008) C. C. Chu et al.   BLOOD

Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14

(2008) P. Ouillette et al.   CANCER RESEARCH

Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

(2008) P. Ghia et al.   JOURNAL OF INTERNAL MEDICINE

Unknown

(2008) Rosa Catera et al.   MOLECULAR MEDICINE

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

(2008) Maria Chiara Di Bernardo et al.   NATURE GENETICS

Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

(2008) Andy C. Rawstron et al.   NEW ENGLAND JOURNAL OF MEDICINE

MiR-15a and miR-16-1 cluster functions in human leukemia

(2008) George A. Calin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA